These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25842913)

  • 41. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
    Saussele T
    Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
    Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
    Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of lacosamide for the treatment of partial-onset seizures.
    Doty P; Hebert D; Mathy FX; Byrnes W; Zackheim J; Simontacchi K
    Ann N Y Acad Sci; 2013 Jul; 1291(1):56-68. PubMed ID: 23859801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.
    Rastogi RG; Ng YT
    J Child Neurol; 2012 Apr; 27(4):492-5. PubMed ID: 22467791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lacosamide for the treatment of partial-onset seizures.
    Biton V
    Expert Rev Neurother; 2012 Jun; 12(6):645-55. PubMed ID: 22650166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G; Szucs A
    Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial.
    Elger CE; Rademacher M; Brandt C; Elmoufti S; Dedeken P; Eckhardt K; Tennigkeit F; De Backer M
    Epilepsy Behav; 2016 Sep; 62():1-5. PubMed ID: 27423106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.
    Marson AG; Hutton JL; Leach JP; Castillo S; Schmidt D; White S; Chaisewikul R; Privitera M; Chadwick DW
    Epilepsy Res; 2001 Sep; 46(3):259-70. PubMed ID: 11518627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lacosamide: in partial-onset seizures.
    Cross SA; Curran MP
    Drugs; 2009; 69(4):449-59. PubMed ID: 19323588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lacosamide for the treatment of epilepsy.
    Krauss GL; Edwards HB; Lin B
    Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lacosamide in patients with epilepsy of cerebrovascular etiology.
    Rosenow F; Brandt C; Bozorg A; Dimova S; Steiniger-Brach B; Zhang Y; Ferrò B; Holmes GL; Kälviäinen R
    Acta Neurol Scand; 2020 Jun; 141(6):473-482. PubMed ID: 32068241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
    Scott LJ
    Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.